Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Not Confirmed
Not Confirmed
03-05 April, 2025
Not Confirmed
Not Confirmed
05-09 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Industry Trade Show
Not Confirmed
03-05 April, 2025
Industry Trade Show
Not Confirmed
05-09 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050972/0/en/aTyr-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
26 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/26/3049634/0/en/aTyr-Pharma-Announces-the-Appointment-of-Dalia-R-Rayes-as-Head-of-Commercial-Global-Efzofitimod-Franchise.html
13 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/13/3042569/0/en/aTyr-Pharma-Announces-Fourth-Quarter-and-Full-Year-2024-Results-and-Provides-Corporate-Update.html
12 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/12/3041728/0/en/aTyr-Pharma-Announces-Publication-Demonstrating-Efzofitimod-s-Immunomodulatory-Activity-in-Science-Translational-Medicine.html
06 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/06/3038599/0/en/aTyr-Pharma-Announces-Fourth-Positive-DSMB-Review-for-Efzofitimod-in-Phase-3-EFZO-FIT-Study-in-Pulmonary-Sarcoidosis.html
04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/04/3036453/0/en/aTyr-Pharma-to-Webcast-Conference-Call-Reporting-Fourth-Quarter-and-Full-Year-End-2024-Financial-Results.html
ABOUT THIS PAGE